Literature DB >> 22454430

RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development.

Julia Yue Cui1, Sumedha S Gunewardena, Byunggil Yoo, Jie Liu, Helen J Renaud, Hong Lu, Xiao-bo Zhong, Curtis D Klaassen.   

Abstract

During development, the maturation of liver transporters is essential for chemical elimination in newborns and children. One cannot compare the real abundance of transcripts by conventional messenger RNA (mRNA) profiling methods; in comparison, RNA-Seq provides a "true quantification" of transcript counts and an unbiased detection of novel transcripts. The purpose of this study was to compare the mRNA abundance of liver transporters and seek their novel transcripts during liver development. Livers from male C57BL/6J mice were collected at 12 ages from prenatal to adulthood. The transcriptome was determined by RNA-Seq, with transcript abundance estimated by Cufflinks. Among 498 known transporters, the ontogeny of 62 known critical xenobiotic transporters was examined in detail. The cumulative mRNAs of the uptake transporters increased more than the efflux transporters in livers after birth. A heatmap revealed three ontogenic patterns of these transporters, namely perinatal (reaching maximal expression before birth), adolescent (about 20 days), and adult enriched (about 60 days of age). Before birth, equilibrative nucleoside transporter 1 was the transporter with highest expression in liver (29%), followed by breast cancer resistance protein (Bcrp) (26%). Within 1 day after birth, the mRNAs of these two transporters decreased markedly, and Ntcp became the transporter with highest expression (52%). In adult liver, the transporters with highest expression were organic cation transporter 1 and Ntcp (23% and 22%, respectively). Three isoforms of Bcrp with alternate leading exons were identified (E1a, E1b, and E1c), with E1b being the major isoform. In conclusion, this study reveals the mRNA abundance of transporters in liver and demonstrates that the expression of liver transporters is both age and isoform specific.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454430      PMCID: PMC3355312          DOI: 10.1093/toxsci/kfs107

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  60 in total

Review 1.  Alternative splicing and diversity of renal transporters.

Authors:  G Gamba
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

Review 2.  Impact of drug transporter studies on drug discovery and development.

Authors:  Naomi Mizuno; Takuro Niwa; Yoshihisa Yotsumoto; Yuichi Sugiyama
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

Review 3.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; Y Hamon; G Chimini
Journal:  J Lipid Res       Date:  2001-07       Impact factor: 5.922

Review 4.  Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes.

Authors:  Benjamin J Blencowe; Sidrah Ahmad; Leo J Lee
Journal:  Genes Dev       Date:  2009-06-15       Impact factor: 11.361

5.  Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta.

Authors:  Joyce J Repa; Knut E Berge; Chris Pomajzl; James A Richardson; Helen Hobbs; David J Mangelsdorf
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

Review 6.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

7.  Developmental aspects of human hepatic drug glucuronidation in young children and adults.

Authors:  C P Strassburg; A Strassburg; S Kneip; A Barut; R H Tukey; B Rodeck; M P Manns
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

8.  The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.

Authors:  Lin Wang; Carol J Soroka; James L Boyer
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 9.  Developmental pharmacology--drug disposition, action, and therapy in infants and children.

Authors:  Gregory L Kearns; Susan M Abdel-Rahman; Sarah W Alander; Douglas L Blowey; J Steven Leeder; Ralph E Kauffman
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

10.  Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein.

Authors:  Renxue Wang; Ping Lam; Lin Liu; Dana Forrest; Ibrahim M Yousef; Diane Mignault; M James Phillips; Victor Ling
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

View more
  26 in total

1.  Hepatic ontogeny and tissue distribution of mRNAs of epigenetic modifiers in mice using RNA-sequencing.

Authors:  Hong Lu; Julia Yue Cui; Sumedha Gunewardena; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Epigenetics       Date:  2012-07-09       Impact factor: 4.528

Review 2.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

3.  Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice.

Authors:  Felcy Pavithra Selwyn; Sunny Lihua Cheng; Theo K Bammler; Bhagwat Prasad; Marc Vrana; Curtis Klaassen; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2015-06-01       Impact factor: 4.849

Review 4.  From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century.

Authors:  Supratim Choudhuri; Geoffrey W Patton; Ronald F Chanderbhan; Antonia Mattia; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2018-01-01       Impact factor: 4.849

5.  RNA-Seq provides new insights on the relative mRNA abundance of antioxidant components during mouse liver development.

Authors:  Kai Connie Wu; Julia Yue Cui; Jie Liu; Hong Lu; Xiao-Bo Zhong; Curtis D Klaassen
Journal:  Free Radic Biol Med       Date:  2019-01-16       Impact factor: 7.376

Review 6.  Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.

Authors:  Jonathan Wagner; J Steven Leeder
Journal:  Pediatr Clin North Am       Date:  2012-08-22       Impact factor: 3.278

7.  RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice.

Authors:  Hong Lu; Sumedha Gunewardena; Julia Y Cui; Byunggil Yoo; Xiao-bo Zhong; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-02-04       Impact factor: 3.922

8.  Age-Specific Regulation of Drug-Processing Genes in Mouse Liver by Ligands of Xenobiotic-Sensing Transcription Factors.

Authors:  Cindy Yanfei Li; Helen J Renaud; Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-11-17       Impact factor: 3.922

Review 9.  Methodologies to decipher the cell secretome.

Authors:  Paromita Mukherjee; Sridhar Mani
Journal:  Biochim Biophys Acta       Date:  2013-01-31

10.  Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mice.

Authors:  Matthew Pratt-Hyatt; Andrew J Lickteig; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-05-09       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.